
Tirze GLP-2
Tirzepatide research peptide, a dual GIP and GLP-1 receptor agonist, for in-vitro study. 99%+ HPLC, COA on request. Research use only. · USD
Product details
About Tirze GLP-2
Tirzepatide is a synthetic 39-amino-acid peptide based on the GIP sequence that acts as an agonist at both the GIP and GLP-1 receptors. A C20 fatty diacid side chain binds albumin and extends its half-life.
Research background
It is used in research as a reference dual-agonist in receptor-pharmacology and cell-signalling assays, and in preclinical metabolic models. Tirzepatide is the active ingredient in prescription medicines regulated by the FDA. This product is laboratory research material; it is not that medicine, is not manufactured for human use, and must not be used as a substitute for it.
Specifications
- Form: lyophilised (freeze-dried) powder
- Purity: 99%+ by HPLC
- Documentation: Certificate of Analysis available on request
- Storage: keep the sealed vial cold and away from light and moisture
For laboratory research use only
This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, dietary supplement or cosmetic, has not been evaluated by the FDA, and is not for human or animal consumption or for any diagnostic or therapeutic use.
